Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor

ZOI EVANGELOU, ATHINA ZARACHI, JEAN MARC DUMOLLARD, MICHEL PEOC'H, IOANNIS KOMNOS, IOANNIS KASTANIOUDAKIS and GEORGIA KARPATHIOU
In Vivo September 2020, 34 (5) 2249-2258; DOI: https://doi.org/10.21873/invivo.12035
ZOI EVANGELOU
1Department of Pathology and Otorhinolaryngology, University Hospital of Ioannina, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHINA ZARACHI
2Department of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEAN MARC DUMOLLARD
3Department of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHEL PEOC'H
3Department of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS KOMNOS
2Department of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS KASTANIOUDAKIS
2Department of Head and Neck Surgery, University Hospital of Ioannina, Ioannina, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGIA KARPATHIOU
1Department of Pathology and Otorhinolaryngology, University Hospital of Ioannina, Ioannina, Greece
3Department of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gakarpath{at}yahoo.gr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Diagnosis of odontogenic tumors can be challenging due to their rarity and diverse morphology, but when arising near the tooth, the diagnosis could be suspected. When their location is not typical, like inside the paranasal sinuses, the diagnosis is less easy. Maxillary ameloblastomas are exceedingly rare with only sparse information on their epidemiological, histological and genetic characteristics. The aim of this report is to thoroughly review the available literature in order to present the characteristics of this tumor. According to available data, maxillary ameloblastomas can occur in all ages but later than mandible ones, and everywhere within the maxillary region without necessarily having direct contact with the teeth. No sex preference has been shown. The most common histological patterns seen in this location are the follicular and plexiform ones. Maxillary ameloblastomas are locally aggressive neoplasms, thus therapy aims for excision including normal bone beyond the lesion. In contrast to mandible ameloblastomas, maxillary ones most commonly show mutations of the SMO gene. Furthermore, differential tumor diagnosis is thoroughly discussed in the present review.

  • Odontogenic tumor
  • sinonasal tumor
  • nasal polyp
  • head and neck
  • rare tumor
  • adamantinoma
  • review

Odontogenic tumors are rare and can pose diagnostic difficulties for non-specialized pathologists. Nevertheless, when the location is typical, i.e. molar region and when the histology shows the characteristic features of odontogenic neoplasms, diagnosis could be straightforward. In locations outside the oral cavity or when rare histological variants are found, suspecting the correct diagnosis can be challenging. This is especially true for maxillary ameloblastomas, which are rare, possibly leading to low awareness of this neoplasm at this location and often show non-classical morphology, thus, rendering its diagnosis more complicated.

Thus, the aim of this review is to define and thoroughly describe maxillary ameloblastomas based on the available literature after a short introduction in the entity of ameloblastoma.

Introduction to Ameloblastomas. Ameloblatoma, initially called adamantinoma (from the greek word adamantinos αδαμάντινοφ<ἀ-δάμαφ, meaning very hard) from Broca (1) in 1867, belongs to odontogenic tumors. Odontogenic tumors are rare entities that constitute a heterogenous group of neoplasms with a variety of histological types and clinical behaviors (2). Their classification has seen many changes, from attempts to classify these lesions based on their histogenesis (3) or mechanisms of differentiation (4) to reach the final classification scheme set by the World Health Organization in 2017 (5) (Table I). Among all odontogenic tumors, ameloblastomas are the most common to encounter. Based on WHO 2017 (5), ameloblastomas are divided into i. ameloblastoma, which includes the previously named conventional, solid/multicystic and intraosseous ameloblastoma, ii. ameloblastoma, unicystic type, iii. ameloblastoma, extraosseous/peripheral type which includes the previously named soft tissue ameloblastoma, ameloblastoma of mucosal origin or of the gingiva and iv. metastasizing ameloblastoma.

Ameloblastomas are unusual entities that consist of approximately 1% of all benign tumors and cysts of the jaw (6). Their incidence is estimated to be 0.5 cases per million person-years worldwide (7), although in South Africa a slightly higher incidence has been reported (8). There is no sex preference and it is most commonly found in the fourth to fifth decade of life (5).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

WHO 2017 classification of odontogenic tumors (5).

These tumors arise from remnants of the odontogenic epithelium, such as cell rests of the dental lamina, a developing enamel organ, the lining of an odontogenic cyst or the basal cells of the oral mucosa (9). They mostly occur in the mandible (10). Conventional mandible ameloblastomas clinically present as a painless swelling of the posterior mandible, frequently being associated with an unerupted tooth and thus they can be easily detected (11).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Different aspects of maxillary ameloblastomas. (A) Follicular pattern, showing large cell nests with palisading cell layers and a central part of stellate reticulum. (B) Microcystic areas can be seen. (C) Plexiform pattern, showing short strands of cells. (D) Plexiform pattern, showing very thin inter-anastomosing strands in an edematous background.

The typical morphology of ameloblastomas is that of odontogenic epithelial islands simulating the stellate reticulum, peripherally palisaded by columnar cells with reversed nuclear polarity, filled with loosely arranged angulated cells (Figures 1 and 2, best appreciated in Figure 3D). No dentin or enamel (hard elements) formation is found. Ameloblastomas can present with a follicular, plexiform, acanthomatous, basaloid, granular cell or desmoplastic pattern, with no evidence of deviant biological behavior among them (Figure 1) (5). It is not uncommon to have a combination of two or more patterns in a tumor. The follicular pattern is the most common answered (5). It consists of neoplastic cellular nests with central loosening of short spindled epithelial cells resembling the stellate reticulum of the developing tooth germ, surrounded by palisading columnar cells with reverse nuclear polarity. The plexiform pattern shows a lace like architecture consisting of lamina like strands which show two distinct forms: one where the strands are formed by two layers of basaloid cells and a second form where the strands are thicker and looser and the cells have a more squamous appearance. In both cases, this pattern can be deceiving as there is no evident peripheral palisading and reverse nuclear polarity. The acanthomatous pattern shows squamous metaplasia within the stellate reticulum with formation of keratin filled cavities. Granular cell type is characterized by granular change where all or some of the neoplastic cells of the stellate reticulum gain abundant deeply granular cytoplasm (accumulation of lysosomes). The basaloid ameloblastoma shows nuclear crowding and cells with basaloid appearance with or without peripheral palisading or reverse nuclear polarity. The desmoplastic variant is characterized by intense stromal desmoplasia which compresses the neoplastic islands of the epithelium, making it difficult if not impossible to identify the peripheral palisading and reverse nuclear polarity. Extra osseous/peripheral type ameloblastomas can show the same histological patterns as described above, but the follicular, plexiform and acanthomatous patterns, are the ones most commonly seen (5).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Continuity of tumor cells with surface epithelium. Three different cases of maxillary ameloblastomas (C and D, same case in different magnifications) showing the surface epithelium (left) communicating with the underlying tumor nests.

Recent studies have detected gene mutations in the mitogen-activated protein kinase (MAPK) pathway in most ameloblastomas, with mutations most commonly being BRAF V600E as well as KRAS, NRAS, HRAS, and FGFR2 mutations (12).

Simple curettage of the neoplasm is linked to high incidence of recurrence (13). The current treatment of choice is wide surgical excision, including normal bone extending beyond the radiographical margins (5).

Maxillary ameloblastoma

Epidemiology. Ameloblastomas located in the maxillary region are rare compared to those arising in the mandible, the latter being five times more frequent (10). Indeed, maxillary ameloblastomas account for 15% of all ameloblastomas. Most of them arise posterior to the premolars and only 2% of them arise anterior to them (6, 10, 13). The natural history, epidemiology, localization, histopathology and prognostic factors remain unclear since there are only a few case series referring exclusively to maxillary ameloblastomas (Table II). A wide range of ages has been reported for maxillary ameloblastoma, starting from early childhood, with a case of a six-year-old child being the younger patient reported (14) until elderly people with a case of an 81-year-old male were reported (15). It is worth noting that maxillary ameloblastomas occur about 10 years later than those arising in the mandible (11), probably representing the lack of evident early symptoms, while no sex predilection is found (16).

Signs and symptoms. Interestingly, maxillary ameloblastomas in contrast to mandibular ones, have a more aggressive clinical course (10). This is partially explained by the lack of early symptoms, leading to diagnosis at an advanced disease when the tumor has already extended beyond the maxilla (16, 17). When symptoms do develop, they include face deformity, usually unilateral, intraoral ulceration, toothache, headache, nasal obstruction, nasal epistaxis and visual disturbances (18, 19). Another reason for their aggressive behavior is the nature of the maxillary bone (20). In contrast to the compact mandible bone, the maxilla is a cancellous bone, making it easier for the tumor to invade and spread to adjacent structures such as the nasal cavity, paranasal sinuses, orbits, parapharyngeal tissues and skull base (2).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

(A) Different components can be seen in the same tumor (left plexifom, right acanthomatous). (B) Follicular type maxillary ameloblatoma with evident stellate reticulum and palisading. (C) Follicular maxillary ameloblastoma with central spindle squamous cells. (D) The characteristic palisading cells with reversed polarity surrounding central stellate reticulum.

Histogenesis. The histogenesis of maxillary ameloblastomas remains controversial. In our experience, almost all maxillary ameloblastomas will show continuity of the tumoral cells with the overlying epithelium, if thoroughly examined (Figure 3). It has been suggested that maxillary ameloblastoma can derive from the odontogenic epithelium as mentioned above, but given this direct continuity with the overlying mucosal epithelium, an origin from the basal cells has been also hypothesized (15). Ide et al. studied 14 small ameloblastomas of the alveolar region and suggested that residues of odontogenic epithelium can be detected in all facial tissues, whether that is bone, the alveolar process or the gingiva (21). Thus, based on the latter theory, maxillary ameloblastomas can potentially arise everywhere within the maxillary region, without necessarily having direct contact with the teeth.

Location. The maxilla is a bone forming various facial cavities and walls. It is the roof of the mouth, the floor and lateral wall of the nasal cavity and the orbital floor. Thus, it forms part of the oral and nasal cavity, the maxillary sinus and part of the orbital cavity. Ameloblastomas can develop in all maxillary walls and cavities, in which case they are considered maxillary ameloblastomas. Physicians should carefully examine if these tumors are in contact with the maxillary bone. If the ameloblastoma is limited to the soft tissues, then it is considered to be of peripheral/extraosseous type. If bone infiltration is found, then additional characteristics should be used in order to classify it into the categories of conventional or unicystic, as described above for mandible ameloblastomas (Figure 4).

For descriptive reasons, maxillary ameloblastomas are also divided in posterior or anterior tumors (11). The first one is located posterior to the canine, thus it includes the molars and tuberosity and the second one is located anterior to the canine. Some authors also include the middle maxilla as a region of ameloblastomas origin, when they are situated between the canine and maxillary molars (22). Ameloblastomas have a preference to the posterior maxilla, since only 2% have been reported to arise in the anterior region (22).

View this table:
  • View inline
  • View popup
Table II.

Maxillary ameloblastoma. Characteristics of published cases.

Histopathology. The most frequent histological patterns seen in maxillary ameloblastomas are the follicular and plexiform patterns followed by the acanthomatous one, which is observed as a part of mixed type frequently being focal and inconspicuous (Figures 1, 2 and 3) (15, 22). Interestingly, the desmoplastic variant although being a rare variant, shows a predilection for the maxilla (23).

Immunohistochemistry. Although not pathognomonic, immunohistochemistry may be helpful in diagnosing ameloblastoma or excluding entities with histological characteristics similar to ameloblastoma (24). All ameloblastoma cells express CK19, which is considered an odontogenic epithelium marker, including areas of acanthomatous and granular differentiation (25, 26). The stellate reticulum cells usually stain for CK13 and Calretinin (24, 27), while the peripheral cells usually stain for CK14 and CD56 (28, 29). Ameloblastomas have a very low proliferation index (MιB1/Ki67), but malignant ameloblastomas can have a higher proliferation rate of almost 20% (30).

Differential diagnosis. A pathologist should be careful when rendering a diagnosis of ameloblastoma. Not only should he include the possibility of such diagnosis in lesions of the maxillary lesion, but he should also exclude several entities that share similar histological features before reaching his final diagnosis.

Sinonasal papilloma enters this differential diagnosis especially due to to the sinonasal location; inverted papilloma may show some overlapping histological features with ameloblastoma, especially the follicular and acanthomatous ones. However, epithelial cells of inverted papillomas show absence of reversed nuclear polarity, actual absence of stellate reticulum, and there is a basement membrane surrounding nests as well as numerous intraepithelial microcysts mostly containing neutrophils, both findings characteristic of the inverted sinonasal papilloma.

Ameloblastic and odontogenic fibromas characteristically have smaller nests, that generally do not fuse or anastomose and are set in an a more myxoid matrix with numerous stellate fibroblasts. Ameloblastic odontomas have similar epithelial elements as ameloblastoma but they also include hard elements (enamel and dentin). In contrast to ameloblastoma, adenomatoid odontogenic tumor has reverse polarity away from a central lumen and not in the basal layer surrounding nests of cells resembling the stellate reticulum (Table III).

Non-keratinizing squamous cell carcinoma has an anastomosing ribbon like architectural pattern that could resemble ameloblastoma, especially the plexiform pattern, but there is marked nuclear atypia, loss of polarity and numerous mitoses, characteristics not compatible to the latter. Adenoid cystic carcinoma (ACC) in its typical form with cribriform structures may not be a diagnostic problem, however, its solid variant should enter the differential diagnosis of ameloblastoma. Immunohistochemical expression of CD117 in ACC cells could be helpful in this case. Mucoepidermoid carcinoma, may resemble ameloblastoma but attentive examination reveals three cell types, mucous, squamous and intermediate. Basal cell adenocarcinoma is a rare, yet worth to be included in the differential diagnosis entity. The main histological findings are the lack of reverse nuclear polarity, as well as the architectural pattern of basal cell adenocarcinoma, which shows a more confluent pattern rather than the anastomosing pattern seen in ameloblastomas. Basal cell carcinoma can be easily excluded immunohistochemically using keratin 19 which is negative in basal cell carcinoma and positive in ameloblastoma (31).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Maxillary ameloblastomas diagnostic approach.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Suggested references for further reading.

Molecular biology. Maxillary ameloblastomas, as the mandibular ones, have been associated with certain gene mutations. Interestingly, maxillary amenoblastomas do not have the same gene mutations as the mandibular ones. They most frequently harbor a SMO mutation followed by a RAS mutation and less frequently a BRAF or FGFR2 mutation (12).

Treatment. Despite the fact that treatment for mandibular ameloblastomas is relatively well defined, treatment for maxillary ameloblastomas has not yet been established. In brief, simple curettage of maxillary ameloblastomas has up to 100% possibility of local recurrence (13). In contrast, more radical approaches, such as en bloc resection with the possibility of 10-15 mm thickness of normal bone as margin, have shown lower percentages of recurrence (13).

Conclusion

Ameloblastomas are odontogenic epithelial tumors mostly involving the mandible. Maxillary ameloblastomas, on the other hand, are rare and therefore not easy to be suspected. After collecting available literature data, we showed that there is no sex predilection and that maxillary ameloblastoma can arise in all ages, but a decade later than the mandible ones. They can be found anywhere within the maxillary region and they are not necessarily associated to a tooth. The follicular and plexiform types are the most frequently observed histological patterns. In contrast to mandible ameloblastomas, the maxillary ones show SMO mutations followed by RAS mutations and only a few have BRAF and FGFR2 mutations. Excision should be wider for patients with maxillary ameloblastomas since it shows a more aggressive behavior threatening neighboring structures.

Footnotes

  • Authors' Contributions

    All Authors contributed to data collection and analysis. ZE drafted the manuscript. All Authors revised and approved the final form.

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors have no conflicts of interest to disclose.

  • Received June 18, 2020.
  • Revision received July 7, 2020.
  • Accepted July 9, 2020.
  • Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

References

  1. ↵
    1. Broca P
    : Recherches sur un nouveau groupe de tumeurs désignées sous le nom d'odontomes (ed.1867). HACHETTE BNF, 2017.
  2. ↵
    1. Gardner DG
    : A pathologist's approach to the treatment of ameloblastoma. J Oral Maxillofac Surg 42: 161-166, 1984. PMID: 6583361. DOI: 10.1016/s0278-2391(84)80026-9
    OpenUrlCrossRefPubMed
  3. ↵
    1. Thoma KH,
    2. Goldman HM
    : Odontogenic tumors: classification based on observations of the epithelial, mesenchymal, and mixed varieties. Am J Pathol 22: 433-471, 1946. PMID: 19970874.
    OpenUrlPubMed
  4. ↵
    1. Pindborg JJ
    : A calcifying epithelial odontogenic tumor. Cancer 11: 838-843, 1958. PMID: 13561253. DOI: 10.1002/1097-0142(195807/08)11:4<838::AID-CNCR2820110423>3.0.CO;2-5
    OpenUrlCrossRefPubMed
  5. ↵
    1. El-Naggar AK,
    2. Chan JKC,
    3. Grandis JR,
    4. Takata T,
    5. Slootweg PJ
    : WHO classification of head and neck tumours. WHO/IARC classification of tumours. World Heal Organ, 2017.
  6. ↵
    1. Small IA,
    2. Waldron CA
    : Ameloblastomas of the jaws. Oral Surgery, Oral Med Oral Pathol 8: 281-297, 1955. PMID: 14356722. DOI: 10.1016/0030-4220(55)90350-9
    OpenUrl
  7. ↵
    1. Larsson A,
    2. Almeren H
    : Ameloblastoma of the jaws. An analysis of a consecutive series of all cases reported to the Swedish cancer registry during 1958-1971. Acta Pathol Microbiol Scand - Sect A Pathol 86: 337-349, 1978. PMID: 716895. DOI: 10.1111/j.1699-0463.1978.tb02054.x
    OpenUrl
  8. ↵
    1. Shear M,
    2. Singh S
    : Age-standardized incidence rates of ameloblastoma and dentigerous cyst on the Witwatersrand, South Africa. Community Dent Oral Epidemiol 6: 195-199, 1978. PMID: 278703. DOI: 10.1111/j.1600-0528.1978.tb01149.x
    OpenUrlCrossRefPubMed
  9. ↵
    1. Gorlin RJ,
    2. Chaudhry AP,
    3. Pindborg JJ
    : Odontogenic tumors. Classification, histopathology, and clinical behavior in man and domesticated animals. Cancer 14: 73-101, 1961. PMID: 13707265. DOI: 10.1002/1097-0142(196101/02)14:1<73::AID-CNCR2820140111>3.0.CO;2-T
    OpenUrlCrossRefPubMed
  10. ↵
    1. Robinson HBG
    : Ameloblastoma: a survey of 379 cases from the literature. Arch Pathol 23: 440, 1937.
    OpenUrl
  11. ↵
    1. Reichart PA,
    2. Philipsen HP,
    3. Sonner S
    : Ameloblastoma: Biological profile of 3677 cases. Eur J Cancer Part B Oral Oncol 31: 86-99, 1995. PMID: 7633291. DOI: 10.1016/0964-1955(94)00037-5
    OpenUrlCrossRef
  12. ↵
    1. Sweeney RT,
    2. McClary AC,
    3. Myers BR,
    4. Biscocho J,
    5. Neahring L,
    6. Kwei KA,
    7. Qu K,
    8. Gong X,
    9. Ng T,
    10. Jones CD,
    11. Varma S,
    12. Odegaard JI,
    13. Sugiyama T,
    14. Koyota S,
    15. Rubin BP,
    16. Troxell ML,
    17. Pelham RJ,
    18. Zehnder JL,
    19. Beachy PA,
    20. Pollack JR,
    21. West RB
    : Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet 46: 722-725, 2014. PMID: 24859340. DOI: 10.1038/ng.2986
    OpenUrlCrossRefPubMed
  13. ↵
    1. Sehdev MK,
    2. Huvos AG,
    3. Strong EW,
    4. Gerold FP,
    5. Willis GW
    : Ameloblastoma of maxilla and mandible. Cancer 33: 324-333, 1974. PMID: 5318030. DOI: 10.1002/1097-0142(197402)33:2<324::AID-CNCR2820330205>3.0.CO;2-U
    OpenUrlCrossRefPubMed
  14. ↵
    1. Yang R,
    2. Liu Z,
    3. Peng C,
    4. Cao W,
    5. Ji T
    : Maxillary ameloblastoma: Factors associated with risk of recurrence. Head Neck 39: 996-1000, 2017. PMID: 20848441. DOI: 10.1002/hed.24720
    OpenUrl
  15. ↵
    1. Schafer DR,
    2. Thompson LDR,
    3. Smith BC,
    4. Wenig BM
    : Primary ameloblastoma of the sinonasal tract: A clinicopathologic study of 24 cases. Cancer 82: 667-674, 1998. PMID: 9477098. DOI: 10.1002/(SICI)1097-0142(19980215)82:4<667::AID-CNCR8>3.0.CO;2-I
    OpenUrlCrossRefPubMed
  16. ↵
    1. Zwahlen RA,
    2. Grätz KW
    : Maxillary ameloblastomas: A review of the literature and of a 15-year database. J Cranio-Maxillofacial Surg 30: 273-279, 2002. PMID: 12377199. DOI: 10.1016/S1010-5182(02)90317-3
    OpenUrlPubMed
  17. ↵
    1. Corio RL,
    2. Goldblatt LI,
    3. Edwards PA,
    4. Hartman KS
    : Ameloblastic carcinoma: A clinicopathologic study and assessment of eight cases. Oral Surgery, Oral Med Oral Pathol 64: 570-576, 1987. PMID: 3313152. DOI: 10.1016/0030-4220(87)90063-6
    OpenUrl
  18. ↵
    1. Shaw HJ,
    2. Katsikas DK
    : Ameloblastoma of the maxilla a clinical study with four cases. J Laryngol Otol 87: 873-884, 1973. PMID: 4728301. DOI: 10.1017/S0022215100077744
    OpenUrlPubMed
  19. ↵
    1. Abtahi MA,
    2. Zandi A,
    3. Razmjoo H,
    4. Ghaffari S,
    5. Abtahi SM,
    6. Jahanbani-Ardakani H,
    7. Kasaei Z,
    8. Kasaei-Koupaei S,
    9. Sajjadi S,
    10. Sonbolestan SA,
    11. Abtahi SH
    : Orbital invasion of ameloblastoma: A systematic review apropos of a rare entity. J Curr Ophthalmol 30: 23-34, 2018. PMID: 9788857. DOI: 10.1016/j.joco.2017.09.001
    OpenUrl
  20. ↵
    1. Batsakis JG,
    2. Mcclatchey KD
    : Ameloblastoma of the maxilla and peripheral ameloblastomas. Ann Otol Rhinol Laryngol 92: 532-533, 1983. PMID: 6625456. DOI: 10.1177/000348948309200526
    OpenUrlPubMed
  21. ↵
    1. Ide F,
    2. Mishima K,
    3. Yamada H,
    4. Horie N,
    5. Saito I,
    6. Shimoyama T,
    7. Kusama K
    : Unsuspected small ameloblastoma in the alveolar bone: A collaborative study of 14 cases with discussion of their cellular sources. J Oral Pathol Med 37: 221-227, 2008. PMID: 18221325. DOI: 10.1111/j.1600-0714.2007.00628.x
    OpenUrlPubMed
  22. ↵
    1. Nastri AL,
    2. Wiesenfeld D,
    3. Radden BG,
    4. Eveson J,
    5. Scully C
    : Maxillary ameloblastoma: a retrospective study of 13 cases. Br J Oral Maxillofac Surg 33: 28-32, 1995. PMID: 7718524. DOI: 10.1016/0266-4356(95)90082-9
    OpenUrlPubMed
  23. ↵
    1. Philipsen HP,
    2. Reichart PA,
    3. Takata T
    : Desmoplastic ameloblastoma (including “hybrid” lesion of ameloblastoma). Biological profile based on 100 cases from the literature and own files. Oral Oncol 37: 455-460, 2001. PMID: 11377234. DOI: 10.1016/S1368-8375(00)00111-1
    OpenUrlCrossRefPubMed
  24. ↵
    1. Hunter KD,
    2. Speight PM
    : The diagnostic usefulness of immunohistochemistry for odontogenic lesions. Head Neck Pathol 8: 392-399, 2014. PMID: 25409846. DOI: 10.1007/s12105-014-0582-0
    OpenUrlCrossRefPubMed
  25. ↵
    1. Pal SK,
    2. Sakamoto K,
    3. Aragaki T,
    4. Akashi T,
    5. Yamaguchi A
    : The expression profiles of acidic epithelial keratins in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol 115: 523-531, 2013. PMID: 23522646. DOI: 10.1016/j.oooo.2013.01.017
    OpenUrl
  26. ↵
    1. Kishino M,
    2. Murakami S,
    3. Yuki M,
    4. Iida S,
    5. Ogawa Y,
    6. Kogo M,
    7. Toyosawa S
    : A immunohistochemical study of the peripheral ameloblastoma. Oral Dis 13: 575-580, 2007. PMID: 17944675. DOI: 10.1111/j.1601-0825.2006.01340.x
    OpenUrlCrossRefPubMed
  27. ↵
    1. Altini M,
    2. Coleman H,
    3. Doglioni C,
    4. Favia G,
    5. Maiorano E
    : Calretinin expression in ameloblastomas. Histopathology 37: 27-32, 2000. PMID: 10931215. DOI: 10.1046/j.1365-2559.2000.00940.x
    OpenUrlCrossRefPubMed
  28. ↵
    1. Cairns L,
    2. Naidu A,
    3. Robinson CM,
    4. Sloan P,
    5. Wright JM,
    6. Hunter KD
    : CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions. Histopathology 57: 544-548, 2010. PMID: 20875069. DOI: 10.1111/j.1365-2559.2010.03658.x
    OpenUrlPubMed
  29. ↵
    1. Kusafuka K,
    2. Hirobe K,
    3. Wato M,
    4. Tanaka A,
    5. Nakajima T
    : CD56 expression is associated with neuroectodermal differentiation in ameloblastomas: An immunohistochemical evaluation in comparison with odontogenic cystic lesions. Med Mol Morphol 44: 79-85, 2011. PMID: 21717310. DOI: 10.1007/s00795-010-0510-7
    OpenUrlCrossRefPubMed
  30. ↵
    1. Bologna-Molina R,
    2. Mosqueda-Taylor A,
    3. Lopez-Corella E,
    4. De Almeida OP,
    5. Carrasco-Daza D,
    6. Farfán-Morales JE,
    7. Molina-Frechero N,
    8. Damián-Matsumura P
    : Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int 59: 229-233, 2009. PMID: 19351365. DOI: 10.1111/j.1440-1827.2009.02355.x
    OpenUrlCrossRefPubMed
  31. ↵
    1. Vanoven BJ,
    2. Parker NP,
    3. Petruzzelli GJ
    : Peripheral ameloblastoma of the maxilla: a case report and literature review. Am J Otolaryngol - Head Neck Med Surg 29: 357-360, 2008. PMID: 18722894. DOI: 10.1016/j.amjoto.2007.10.002
    OpenUrl
    1. Rockoff HM
    : A statistical analysis of ameloblastoma. Oral Surgery, Oral Med Oral Pathol 16: 1100-1101, 1963. PMID: 14061145. DOI: 10.1016/0030-4220(63)90225-1
    OpenUrl
    1. Bredenkamp JK,
    2. Zimmerman MC,
    3. Mickel RA
    : Maxillary Ameloblastoma: A Potentially Lethal Neoplasm. Arch Otolaryngol Neck Surg 115: 99-104, 1989. PMID: 2642382. DOI: 10.1001/archotol.1989.01860250101036
    OpenUrl
    1. Darshani Gunawardhana KSN,
    2. Jayasooriya PR,
    3. Rambukewela IK,
    4. Tilakaratne WM
    : A clinico-pathological comparison between mandibular and maxillary ameloblastomas in Sri Lanka. J Oral Pathol Med 39: 236-241, 2010. PMID: 20070485. DOI: 10.1111/j.1600-0714.2009.00850.x
    OpenUrlPubMed
    1. Di Cosola M,
    2. Turco M,
    3. Bizzoca G,
    4. Tavoulari K,
    5. Capodiferro S,
    6. Escudero Castaño N,
    7. Lo Muzio L
    : Ameloblastoma of the jaw and maxillary bone: clinical study and report of our experience. Av Odontoestomatol 23: 367-373, 2007.
    OpenUrl
    1. Ogunsalu C,
    2. Scipio E,
    3. Williams N
    : Review of six cases of maxillary ameloblastoma from the West Indies re-entry cryosurgery as prophylactic surgical intervention. West Indian Med J 58: 398-403, 2009. PMID: 20099786.
    OpenUrlPubMed
    1. Slootweg PJ
    : Update on tooth formation mimicking odontogenic neoplasia. Head Neck Pathol 1: 94-98, 2007. PMID: 20614289. DOI: 10.1007/s12105-007-0011-8
    OpenUrlPubMed
    1. Bilodeau EA,
    2. Seethala RR
    : Update on odontogenic tumors: Proceedings of the North American Head and Neck Pathology Society. Head Neck Pathol 13: 457-465, 2019. PMID: 30887391. DOI: 10.1007/s12105-019-01013-5
    OpenUrl
    1. Wright JM,
    2. Vered M
    : Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol 11: 68-77, 2017. PMID: 28247226. DOI: 10.1007/s12105-017-0794-1
    OpenUrl
PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 5
September-October 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor
ZOI EVANGELOU, ATHINA ZARACHI, JEAN MARC DUMOLLARD, MICHEL PEOC'H, IOANNIS KOMNOS, IOANNIS KASTANIOUDAKIS, GEORGIA KARPATHIOU
In Vivo Sep 2020, 34 (5) 2249-2258; DOI: 10.21873/invivo.12035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor
ZOI EVANGELOU, ATHINA ZARACHI, JEAN MARC DUMOLLARD, MICHEL PEOC'H, IOANNIS KOMNOS, IOANNIS KASTANIOUDAKIS, GEORGIA KARPATHIOU
In Vivo Sep 2020, 34 (5) 2249-2258; DOI: 10.21873/invivo.12035
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Maxillary ameloblastoma
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Research Progress on the Microregulatory Mechanisms of Fertilization: A Review
  • Gastric Cancer Invading the Pancreas: A Review of the Role of Pancreatectomy
  • Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review
Show more Reviews

Keywords

  • Odontogenic tumor
  • sinonasal tumor
  • nasal polyp
  • head and neck
  • rare tumor
  • Adamantinoma
  • review
In Vivo

© 2026 In Vivo

Powered by HighWire